Home market Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark.

Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark.

Mehabe
-
0
Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark.

Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark. h/t Holger Zschaepitz

Nasdaq Biotech Index up almost 3% after FDA approved Biogen's Alzheimer drug in disease landmark.

Our Twitter for Quick Updates: Twitter Follow Us

© Newspaper WordPress Theme by TagDiv